The Value of Pre-Screening in the Alzheimer's Prevention Initiative (API) Autosomal Dominant Alzheimer's Disease Trial

ABSTRACT: The Alzheimer's Prevention Initiative (API) Autosomal Dominant Alzheimer's Disease (ADAD) trial evaluates the anti-amyloid-β antibody crenezumab in cognitively unimpaired persons who, based on genetic background and age, are at high imminent risk of clinical progression, and prov...

Full description

Autores:

Rios Romenets, Silvia
Giraldo Chica, Margarita María
López, H.
Piedrahita, F.
Ramos, Claudia Patricia
Acosta Baena, Natalia
Muñoz, C.
Ospina, P.
Tobón Quintero, Carlos Andrés
Cho, William
Ward, M.
Langbaum, Jessica
Tariot, Pierre
Reiman, Eric M.
Lopera Restrepo, Francisco Javier

Tipo de recurso:

Article of investigation

Fecha de publicación:

2018

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/23012

Acceso en línea:

http://hdl.handle.net/10495/23012

Palabra clave:

Enfermedad de Alzheimer
Alzheimer Disease
Prevención de Enfermedades
Disease Prevention
Registros
Records
Autosomal dominant Alzheimer’s disease
Alzheimer’s prevention initiative
Registry
Pre- screening

Rights

openAccess

License

http://creativecommons.org/licenses/by/2.5/co/